Indianapolis, Ind.
Eli Lilly dedicated the Bioproduct Research and Development Laboratory in Indianapolis on May 12, 2008. The 475,000-sf, four-story facility will accommodate 500 scientists and staff in 33 labs engaged in biopharmaceutical research. The project represents the final phase of construction at Lilly’s three-building biotechnology complex. The first two phases include a 250,000-sf bioproduct manufacturing plant and a 10,000-sf research support facility, both completed in fall of 2006. Additionally, Lilly broke ground in April of 2008 on a €400 million biomanufacturing facility in Kinsale, Ireland.
